| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/CBDD.12953 |
| P698 | PubMed publication ID | 28120466 |
| P50 | author | Fateme Haghiralsadat | Q87863224 |
| Behrouz Zandieh-Doulabi | Q87863228 | ||
| Ghassem Amoabediny | Q91934150 | ||
| P2093 | author name string | Marco N Helder | |
| Tymour Forouzanfar | |||
| Mohammad Hasan Sheikhha | |||
| Samira Naderinezhad | |||
| P2860 | cites work | Effects of drug hydrophobicity on liposomal stability | Q46845899 |
| Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis. | Q53589204 | ||
| Regulation of S100A8/A9 (calprotectin) binding to tumor cells by zinc ion and its implication for apoptosis-inducing activity | Q24815095 | ||
| Co-delivery of doxorubicin and SATB1 shRNA by thermosensitive magnetic cationic liposomes for gastric cancer therapy | Q28541628 | ||
| Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma | Q30886810 | ||
| Investigation of temperature-induced phase transitions in DOPC and DPPC phospholipid bilayers using temperature-controlled scanning force microscopy | Q34186068 | ||
| Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer | Q35898159 | ||
| An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation | Q36135564 | ||
| Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation | Q37727030 | ||
| Pharmacological basis of pegylated liposomal doxorubicin: impact on cancer therapy | Q37935987 | ||
| Nanoparticle formulations of cisplatin for cancer therapy | Q38723829 | ||
| Bone-targeted acid-sensitive doxorubicin conjugate micelles as potential osteosarcoma therapeutics | Q38949970 | ||
| Development of stealth liposome coencapsulating doxorubicin and fluoxetine | Q39608885 | ||
| A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy. | Q39841267 | ||
| In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride | Q40383336 | ||
| Comparison of alamar blue and MTT assays for high through-put screening | Q40536316 | ||
| Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies. | Q42562347 | ||
| Factors effect on the loading efficiency of Vitamin C loaded chitosan-coated nanoliposomes | Q43238447 | ||
| Interference by anti-cancer chemotherapeutic agents in the MTT-tumor chemosensitivity assay | Q44845069 | ||
| Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer | Q46515132 | ||
| Interaction of fluoxetine with phosphatidylcholine liposomes | Q46580330 | ||
| P433 | issue | 3 | |
| P921 | main subject | doxorubicin | Q18936 |
| pH sensitivity | Q109678729 | ||
| P304 | page(s) | 368-379 | |
| P577 | publication date | 2017-01-25 | |
| P1433 | published in | Chemical Biology and Drug Design | Q15749458 |
| P1476 | title | New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivity | |
| P478 | volume | 90 |
| Q47900854 | A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery |
| Q99616765 | A multiple drug loaded, functionalized pH-sensitive nanocarrier as therapeutic and epigenetic modulator for osteosarcoma |
| Q55710454 | Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance. |
| Q47375034 | EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment |
| Q92066362 | Preparation and Evaluation of A Novel Liposomal Nano-Formulation in Metastatic Cancer Treatment Studies |
| Q92358630 | Recent advances of drug delivery nanocarriers in osteosarcoma treatment |
Search more.